Chinese Journal of Tissue Engineering Research ›› 2014, Vol. 18 ›› Issue (52): 8376-8381.doi: 10.3969/j.issn.2095-4344.2014.52.003

Previous Articles     Next Articles

Effect of freeze-dried bone xenograft and platelet-rich fibrin compound on osteogenesis and osseointegration of alveolar bone defects  

Li Bing-ting1, Jia Ying-zhen1, Liu Zhi-fang1, Song Yuan2, Hou Xiao-wei1   

  1. 1Department of Prosthodontics, Third Affiliated Hospital of Hebei Medical University, Shijiazhuang 050000, Hebei Province, China; 2Hebei Yiling Hospital, Shijiazhuang 050000, Hebei Province, China
  • Revised:2014-11-11 Online:2014-12-17 Published:2014-12-17
  • Contact: Hou Xiao-wei, Chief physician, Department of Prosthodontics, Third Affiliated Hospital of Hebei Medical University, Shijiazhuang 050000, Hebei Province, China
  • About author:Li Bing-ting, Studying for master’s degree, Department of Prosthodontics, Third Affiliated Hospital of Hebei Medical University, Shijiazhuang 050000, Hebei Province, China

Abstract:

BACKGROUND: Freeze-dried bone xenograft has good osteoconductive ability and low antigenicity, but exhibits relatively poor osteoinductive ability. However, autologous platelet rich fibrin possesses good osteoinductive ability.

OBJECTIVE: To observe the effect of freeze-dried bone xenograft/platelet rich fibrin compound on bone defect repairing and osseointegration around the implant. 
METHODS: Twelve normal New Zealand white rabbits were used to prepare the bone defect models at the edentulous area of the bilateral mandible. One titanium screw was implanted in the mesial and distal bone wall of bilateral bone defects respectively. The defects in the right side as experimental group were filled with freeze-dried bone xenograft/platelet rich fibrin compound, while the left defects as control group were inserted only by the freeze-dried bone xenograft. The intact mandible specimens were harvested at 4, 8, 12 weeks after implantation separately, and tested by gross observation, torque test and histological observation.
RESULTS AND CONCLUSION: At 4 weeks after implantation, the experimental group had new vessel formation and a large amount of osteoblasts that were arranged tightly within the monolayer on the surface of newborn bone trabecula; the control group was found to have inflammatory cell infiltration, an increase in fibrous tissue and sparse new vessels, but the number of osteoblasts and new bones was less than that of the experimental group. At 8 weeks after implantation, a great amount of new vessels were seen in the experimental group, and dense bone trabeculae exhibited a mesh-like interconnection, part of which were gradually fused in an island-like shape; in the control group, the number of new vessels was less than that of the experimental group, and the bone trabeculae were slim and scattered. At 12 weeks after implantation, the newborn bone tissue was mature and highly calcified bone trabeculae were seen in the experimental group with formation of lamellar bone; in the control group, the bone trabeculae were integrated into the film that tended to be mature, but the maturity was less than that of the experimental group. Implant-bone bonding strength was higher in the experimental group than the control group at different time points     (P < 0.05). These findings indicate that platelet rich fibrin/freeze-dried bone xenograft compound displays good bone repair and osseointegration abilities.

中国组织工程研究杂志出版内容重点:生物材料;骨生物材料; 口腔生物材料; 纳米材料; 缓释材料; 材料相容性;组织工程


全文链接:

Key words: biocompatible materials, tissue engineering, compomers

CLC Number: